Vanguard Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for Sage Therapeutics Inc Common Stock (SAGE)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
SAGE
Shares outstanding
62.7M shares
Disclosed Ownership
3.27M shares
Ownership
5.21%
Form type
SCHEDULE 13G/A
Date filed
7/29/2025, 02:32 PM
Date of event
Jun 30, 2025
Previous filing
Jan 31, 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 5.21% 3.27M 0 23.7K Ashley Grim Head of Global Fund Administration